Medline (MDLN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 27, 2026
- EPS actual
- $0.50
- EPS estimate
- $0.32
- EPS surprise
- +55.23%
- Revenue surprise
- +2.32%
- Revenue
- $7.7B
- Revenue estimate
- $7.5B
- Reported
- Aug 5, 2026
Medline reported Q2 2026 results, for the quarter ended June 27, 2026, on August 5, 2026. Earnings per share were $0.50, ahead of the $0.32 estimate by 55.23%. Revenue was $7.7 billion against a $7.5 billion consensus, a 2.32% beat. The table has no figures for Q2 2025, so no year-over-year comparison is possible.
The record is short, with only three quarters in the table. Q4 2025, reported February 25, 2026, showed EPS of $0.22, below the $0.24 estimate by 5.59%, on revenue of $7.8 billion. Q1 2026, reported May 6, 2026, brought EPS of $0.33 against a $0.30 estimate, an 11.79% beat, on $7.4 billion in revenue. EPS has risen in each quarter shown, and Q2 2026 was about 52% above Q1. Revenue has stayed in a narrow range of $7.4 billion to $7.8 billion. The two quarters of 2026 add up to $0.83 per share. Three quarters are too few to show a seasonal pattern.
The table has no earlier Q3 report to read timing from. The last two reports came 91 days apart, and if that spacing holds, the next report would fall around early November 2026. It will add a fourth quarter to the record.
Earnings history
Quarterly revenue
Frequently asked questions
When did Medline (MDLN) last report earnings?
Medline last reported on Aug 5, 2026, covering fiscal Q2 2026.
Did MDLN beat earnings estimates?
Yes. Medline reported EPS of $0.50 for Q2 2026 against a $0.32 estimate — a 55.23% beat.
How much revenue did MDLN report last quarter?
Medline reported $7.7B in revenue for Q2 2026, against a consensus estimate of $7.5B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.